SEC Form 4 · accession 0001209191-16-139194
HTG MOLECULAR DIAGNOSTICS, INC · HTGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick C. Roche
Officer — SVP Research & Development
Period of report
Aug 26, 2016
Accepted (ET)
Aug 30, 2016 · 6:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001169987
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 26, 2016 | A | 20,000 | $0.00 | A | 40,080 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F150% of the shares vest on February 27, 2017 and the remainder of the shares (50%) vest on August 28, 2017.